ES2066003T3 - Esteroides aromaticos sustituidos con acido sulfonico como inhibidores del esteroide 5-alfa-reductasa. - Google Patents
Esteroides aromaticos sustituidos con acido sulfonico como inhibidores del esteroide 5-alfa-reductasa.Info
- Publication number
- ES2066003T3 ES2066003T3 ES89313260T ES89313260T ES2066003T3 ES 2066003 T3 ES2066003 T3 ES 2066003T3 ES 89313260 T ES89313260 T ES 89313260T ES 89313260 T ES89313260 T ES 89313260T ES 2066003 T3 ES2066003 T3 ES 2066003T3
- Authority
- ES
- Spain
- Prior art keywords
- reductase
- inhibitors
- steroid
- alpha
- sulphonic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 108010029908 3-oxo-5-alpha-steroid 4-dehydrogenase Proteins 0.000 title 1
- 102000001779 3-oxo-5-alpha-steroid 4-dehydrogenase Human genes 0.000 title 1
- 150000003431 steroids Chemical group 0.000 title 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-N sulfonic acid Chemical group OS(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-N 0.000 title 1
- -1 ACETOXY Chemical group 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical group [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical group [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/003—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
COMPONENTES DE ESTRUCTURA (I) EN LA QUE LAS LINEAS DOTADAS INDICAN LA PRESENCIA OPCIONAL DE UN DOBLE ENLACE, X1, X2 Y X3 SON H, HALOGENO, CF3, ALQUIL C1-6, ALCOXI C1-6, CN, NO2, N(R1)2, CHO O CO2R1; R1 ES H O ALQUIL C1-8 Y R ES HIDROGENO, HIDROXI O ACETOXI; PROCESOS PARA SU PREPARACION, COMPOSICIONES QUE LOS CONTIENEN Y SU USO EN MEDICINA COMO INHIBIDORES DE REDUCTASA-A-5.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/290,020 US4970205A (en) | 1988-12-23 | 1988-12-23 | Sulfonic acid substituted aromatic steroids as inhibitors of steroid 5-α-reductase |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2066003T3 true ES2066003T3 (es) | 1995-03-01 |
Family
ID=23114202
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES89313260T Expired - Lifetime ES2066003T3 (es) | 1988-12-23 | 1989-12-19 | Esteroides aromaticos sustituidos con acido sulfonico como inhibidores del esteroide 5-alfa-reductasa. |
Country Status (14)
Country | Link |
---|---|
US (1) | US4970205A (es) |
EP (1) | EP0375347B1 (es) |
JP (1) | JPH02225494A (es) |
CN (1) | CN1051181A (es) |
AT (1) | ATE115960T1 (es) |
AU (2) | AU627528B2 (es) |
CA (1) | CA2005215A1 (es) |
DE (1) | DE68920128T2 (es) |
DK (1) | DK645189A (es) |
ES (1) | ES2066003T3 (es) |
GR (1) | GR3015476T3 (es) |
IE (1) | IE894108L (es) |
PT (1) | PT92719A (es) |
ZA (1) | ZA899669B (es) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5138063A (en) * | 1984-02-27 | 1992-08-11 | Merck & Co., Inc. | 17β-methoxycarbonyl-4-aza-androsten-1-en-3-ones |
US5571817A (en) * | 1984-02-27 | 1996-11-05 | Merck & Co., Inc. | Methods of treating androgenic alopecia with finasteride [17β-N-mono-substituted-carbamoyl-4-aza-5-α-androst-1-en-ones] |
US5162332A (en) * | 1990-06-20 | 1992-11-10 | Merck & Co., Inc. | Selected 17 β-polyaroyl-4-aza-5 α-androst-1-en-3-ones as steroidal reductase inhibitors |
US5061802A (en) * | 1990-06-20 | 1991-10-29 | Merck & Co. Inc. | 17β-aminobenzoyl-4-aza-5α-androst-1-en-3-ones as benign prostatic hypertrophy agents |
US5151430A (en) * | 1990-06-20 | 1992-09-29 | Merck & Co., Inc. | Specific 17β-thiobenzoyl-4-aza-5α-androst-1-en-3-ones as antiandrogen agents |
US5098908A (en) * | 1990-06-20 | 1992-03-24 | Merck & Co., Inc. | 17β-hydroxybenzoyl-4-aza-5α-androst-1-en-3-ones as testosterone reductase inhibitors |
US5300294A (en) * | 1990-06-27 | 1994-04-05 | Smithkline Beecham Corporation | Method of treating prostatic adenocarcinoma |
US5091380A (en) * | 1990-06-28 | 1992-02-25 | Merck & Co., Inc. | N-monosubstituted adamantyl/norbornanyl 17β-carbamides of 3-carboxy-androst-3,5-dienes as testosterone 5α-reductase inhibitors |
IL101243A (en) * | 1991-03-20 | 1999-12-22 | Merck & Co Inc | Pharmaceutical preparations for the treatment of benign prostatic hyperplasia containing steroid history |
IL104303A0 (en) * | 1992-01-06 | 1993-05-13 | Smithkline Beecham Corp | Process |
RU94046044A (ru) * | 1992-05-20 | 1996-10-10 | Мерк Энд Ко. | Новые 7 бета -замещенные 4-аза- 5 альфа -холестан-оны в качестве ингибиторов 5 альфа -редуктазы, фармацевтическая композиция на их основе, способ ее получения |
EP0641204B1 (en) * | 1992-05-20 | 2000-08-16 | Merck & Co. Inc. | 17-ethers and thioethers of 4-aza-steroids |
DE69329856D1 (de) * | 1992-05-20 | 2001-02-15 | Merck & Co Inc | Ester derivate von 4-aza-steroiden |
ATE195129T1 (de) * | 1992-05-20 | 2000-08-15 | Merck & Co Inc | 4-azasteroide als 5-alpha-reduktase |
AU675225B2 (en) * | 1992-05-20 | 1997-01-30 | Merck & Co., Inc. | 17-amino substituted 4-azasteroid 5alpha-reductase inhibitors |
US5237064A (en) * | 1992-05-20 | 1993-08-17 | Merck & Co., Inc. | Process for producing 7β-substituted-aza-5αandrostan-3-ones |
WO1993023053A1 (en) * | 1992-05-21 | 1993-11-25 | Endorecherche Inc. | INHIBITORS OF TESTOSTERONE 5α-REDUCTASE ACTIVITY |
JPH0641038A (ja) | 1992-07-17 | 1994-02-15 | Mitsubishi Kasei Corp | カルボン酸誘導体 |
US5324734A (en) * | 1992-09-15 | 1994-06-28 | Merck & Co., Inc. | Oxidization metabolites of 5-α-23-methyl-4-aza-21-nor-chol-1-ene-3, 20-dione |
US5278159A (en) * | 1992-10-06 | 1994-01-11 | Merck & Co., Inc. | Aryl ester derivatives of 3-oxo-4-aza-androstane 17-β-carboxylates as 5-α-reductase inhibitors |
US5359071A (en) * | 1993-03-12 | 1994-10-25 | Merck & Co., Inc. | 15-substituted 4-azasteroids |
AU6413594A (en) * | 1993-03-24 | 1994-10-11 | Merck & Co., Inc. | Substituted 3-phenanthridinone derivatives as 5alpha-reductase inhibitors |
JP3325026B2 (ja) * | 1993-06-28 | 2002-09-17 | メルク エンド カンパニー インコーポレーテッド | 4−アザ−プレグナン5α−レダクターゼアイソザイム1阻害剤 |
TW369521B (en) * | 1993-09-17 | 1999-09-11 | Smithkline Beecham Corp | Androstenone derivative |
US5637310A (en) * | 1993-12-20 | 1997-06-10 | Smithkline Beecham Corporation | Method of treating prostatic adenocarcinoma |
DE4447714C2 (de) * | 1994-08-09 | 1998-02-05 | Jenapharm Gmbh | Verwendung von Estra-1,3,5(10)-trien-Derivaten zur Hormonsubstitutions-Therapie |
US5541322A (en) * | 1994-10-14 | 1996-07-30 | Glaxo Wellcome Inc. | Synthesis of 6-azaandrostenones |
ATE473759T1 (de) | 1998-05-22 | 2010-07-15 | Univ Leland Stanford Junior | Bifunktionelle moleküle sowie darauf basierende therapien. |
CN103259027A (zh) | 2005-04-28 | 2013-08-21 | 普罗透斯数字保健公司 | 药物信息系统 |
JP2009508494A (ja) | 2005-09-16 | 2009-03-05 | ラプトール ファーマシューティカル インコーポレイテッド | Crを含むタンパク質に対して特異的な受容体−結合タンパク質(rap)変異体を含む組成物およびその使用 |
CN100355772C (zh) * | 2005-12-28 | 2007-12-19 | 天津大学 | 具有5α-还原酶抑制活性的甾体化合物及其制备方法 |
PT2398500T (pt) | 2009-02-20 | 2019-06-14 | 2 Bbb Medicines B V | Sistema de entrega de medicamentos à base de glutationas |
TWI556839B (zh) | 2009-05-06 | 2016-11-11 | 研究室護膚股份有限公司 | 包含活性劑-磷酸鈣粒子複合物之皮膚遞送組成物及其使用方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2555579A (en) * | 1950-05-24 | 1951-06-05 | Ayerst Mckenna & Harrison | P-aminobenzoyl-diethyl aminoethanol salts of steroids 3-monosulphates |
DE1107664B (de) * | 1959-11-05 | 1961-05-31 | Schering Ag | Verfahren zur Herstellung neuer in 3-Stellung substituierter OEstratriene |
FR1521896A (fr) * | 1966-05-04 | 1968-04-19 | Ohio State University Represen | Procédé de transformation de thioncarbamates en thiolcarbamates |
FR2022104A1 (es) * | 1968-07-24 | 1970-07-31 | Farmaceutici Italia | |
US4191759A (en) * | 1978-04-13 | 1980-03-04 | Merck & Co., Inc. | N-substituted-17β-carbamoylandrost-4-en-3-one 5α reductase inhibitors |
US4179453A (en) * | 1978-04-13 | 1979-12-18 | Merck & Co., Inc. | Process for preparing 17β-carboxy-5-androsten-3-ones |
US4377584A (en) * | 1978-04-13 | 1983-03-22 | Merck & Co., Inc. | 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors |
US4317817A (en) * | 1979-08-27 | 1982-03-02 | Richardson-Merrell Inc. | Novel steroid 5α-reductase inhibitors |
DK465481A (da) * | 1980-11-21 | 1982-05-22 | Hoffmann La Roche | Fremgangsmaade til fremstilling af d-homostemoider |
JPS5953417A (ja) * | 1982-09-21 | 1984-03-28 | Shiseido Co Ltd | 皮膚外用剤 |
JPS60116657A (ja) * | 1983-11-30 | 1985-06-24 | Ono Pharmaceut Co Ltd | アニリン誘導体 |
JPS60142941A (ja) * | 1983-12-28 | 1985-07-29 | Ono Pharmaceut Co Ltd | ケトン化合物 |
JPS60146855A (ja) * | 1984-01-11 | 1985-08-02 | Ono Pharmaceut Co Ltd | アニリン誘導体 |
CA1261835A (en) * | 1984-08-20 | 1989-09-26 | Masaaki Toda | (fused) benz(thio)amides |
US4910226A (en) * | 1987-04-29 | 1990-03-20 | Smithkline Beckman Corporation | Steroid 5-alpha-reductase inhibitors |
-
1988
- 1988-12-23 US US07/290,020 patent/US4970205A/en not_active Expired - Fee Related
-
1989
- 1989-10-24 CN CN89108217A patent/CN1051181A/zh active Pending
- 1989-12-12 CA CA002005215A patent/CA2005215A1/en not_active Abandoned
- 1989-12-18 ZA ZA899669A patent/ZA899669B/xx unknown
- 1989-12-19 EP EP89313260A patent/EP0375347B1/en not_active Expired - Lifetime
- 1989-12-19 AT AT89313260T patent/ATE115960T1/de not_active IP Right Cessation
- 1989-12-19 DK DK645189A patent/DK645189A/da not_active Application Discontinuation
- 1989-12-19 DE DE68920128T patent/DE68920128T2/de not_active Expired - Fee Related
- 1989-12-19 ES ES89313260T patent/ES2066003T3/es not_active Expired - Lifetime
- 1989-12-20 IE IE894108A patent/IE894108L/xx unknown
- 1989-12-20 JP JP1330927A patent/JPH02225494A/ja active Pending
- 1989-12-20 AU AU47005/89A patent/AU627528B2/en not_active Ceased
- 1989-12-22 PT PT92719A patent/PT92719A/pt not_active Application Discontinuation
-
1992
- 1992-11-24 AU AU29602/92A patent/AU655691B2/en not_active Ceased
-
1995
- 1995-03-20 GR GR950400607T patent/GR3015476T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
US4970205A (en) | 1990-11-13 |
DK645189D0 (da) | 1989-12-19 |
CN1051181A (zh) | 1991-05-08 |
AU655691B2 (en) | 1995-01-05 |
DE68920128T2 (de) | 1995-05-11 |
AU627528B2 (en) | 1992-08-27 |
IE894108L (en) | 1990-06-23 |
EP0375347B1 (en) | 1994-12-21 |
ZA899669B (en) | 1990-11-28 |
CA2005215A1 (en) | 1990-06-23 |
GR3015476T3 (en) | 1995-06-30 |
DK645189A (da) | 1990-06-24 |
DE68920128D1 (de) | 1995-02-02 |
AU2960292A (en) | 1993-01-21 |
PT92719A (pt) | 1990-06-29 |
EP0375347A1 (en) | 1990-06-27 |
AU4700589A (en) | 1990-06-28 |
ATE115960T1 (de) | 1995-01-15 |
JPH02225494A (ja) | 1990-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2066003T3 (es) | Esteroides aromaticos sustituidos con acido sulfonico como inhibidores del esteroide 5-alfa-reductasa. | |
IE894109L (en) | Phosphinic acid substituted aromatic steroids as inhibitors¹of steroid 5ó-reductase | |
DE68919660D1 (de) | Phosphonsäure-Derivate von aromatischen Steroiden als 5-alpha-Reduktase-Inhibitoren. | |
ES2111092T3 (es) | Derivados de acidos biliares, procedimiento para su preparacion y utilizacion de estos compuestos como medicamentos. | |
MX9200374A (es) | Nuevos esteres esteroides, procedimiento para su preparacion y preparacion farmaceutica que los contiene. | |
IT8567825A0 (it) | Derivati del naftalene aventi azione retinoide procedimento per la loro preparazione e composizioni medicinali o cosmetiche che li con tengono | |
FR2437396B1 (fr) | Derives d'acide carboxylique d'alcanol monoamines tertiaires | |
ES2142353T3 (es) | Procedimiento para reducir los niveles de colesterol total y de colesterol asociado a lipoproteinas de baja densidad en sangre. | |
MX9205208A (es) | Compuestos derivados del acido 5-amino-4-hidroxihexanoico, procedimiento para su preparacion y compociciones farmaceuticas que los contienen | |
IT8848730A0 (it) | Derivati 17beta-oh 19-nor steroidei sostituiti in 17alfa, procedimento di preparazione, loro impiego come medicamenti e composizioni farmaceutiche che li compongono | |
ES2082057T3 (es) | Esteres del acido acrilico pirimidil-substituidos. | |
IT8249457A0 (it) | Derivati del ciclopropano, loro procedimento di preparazione, loro impiego come agenti profumanti e composizioni che li contengono | |
AR241157A1 (es) | Derivados de la imida del acido n-fenil-3,4,5,6-tetrahidroftalico, procedimiento para su preparacion y composiciones que los contienen | |
PT89311A (pt) | Processo para a preparacao de novos aminoalcoxi-p-benzonitrilos substituidos utilizaveis como agentes antiarritmicos e de composicoes farmaceuticas que os contem | |
IT8247965A0 (it) | Derivati di acido benzoico e formulazioni farmaceutiche che li contengono, per il controllo o l'abbassamento della lipidemia, e procedimento per la loro preparazione | |
ES2082468T3 (es) | Arilalquil esteres del acido 4,5-dihidroxi-9,10-dihidro-9,10-dioxo-2-antracenocarboxilico con actividad terapeutica. | |
MX9203642A (es) | Compuestos substituidos del acido 1,3,4,9-tetrahidropirano (3,4-b)-indol-1-acetico y composiciones farmaceuticas que los contienen. | |
DE876858C (de) | Kleinstschalttafel | |
YU46838B (sh) | Postupak za dobijanje preparata za lečenje kožne bolesti psoriazisa | |
ES2070202T3 (es) | Nuevos derivados de serina, procedimiento para su preparacion y su uso en terapia humana. | |
ES2081127T3 (es) | Composiciones de acido fluorhidrico. | |
ES2076248T3 (es) | Dibenzofuranos substituidos y metodos para el uso de los mismos. | |
ES2069990T3 (es) | Acido acilaminoalquilidenhidroxibisfosfonico util en la terapia de enfermedades osteoarticulares. | |
IT1146156B (it) | Derivati di acido 2 idrossi 5(1 idrossi 2 4(2 osso 1 benzimidazolinil) piperidino) etil benzoico e procedimento per la loro preparazione | |
DE359220C (de) | Verfahren zur Einstellung von umlaufenden elektrischen Zaehlern |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 375347 Country of ref document: ES |